Skip to results
Modify your search
NARROW
1-5 of 5
Authors: Dirk Müller-Wieland
Journal Article
EDITOR'S CHOICE
Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction Get access
European Heart Journal, Volume 45, Issue 48, 21 December 2024, Pages 5117–5126, https://doi.org/10.1093/eurheartj/ehae533
Published: 10 October 2024
Journal Article
The ‘10 commandments’ for the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
European Heart Journal, Volume 45, Issue 15, 14 April 2024, Pages 1298–1300, https://doi.org/10.1093/eurheartj/ehad881
Published: 09 January 2024
Journal Article
GUIDELINES
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC)
European Heart Journal, Volume 44, Issue 39, 14 October 2023, Pages 4043–4140, https://doi.org/10.1093/eurheartj/ehad192
Published: 25 August 2023
Journal Article
SGLT2 inhibitors in heart failure and type 2 diabetes: from efficacy in trials towards effectiveness in the real world
European Heart Journal, Volume 44, Issue 24, 21 June 2023, Pages 2231–2233, https://doi.org/10.1093/eurheartj/ehad282
Published: 08 June 2023
Journal Article
EDITOR'S CHOICE
No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies
European Heart Journal, Volume 37, Issue 39, 14 October 2016, Pages 2981–2989, https://doi.org/10.1093/eurheartj/ehw292
Published: 26 July 2016
